title: [Prostatic carcinoma. Zoledronic acid raises bone density].
authors.forename: Manfred
authors.initials: M
authors.lastname: Wirth
authors.forename: Michael
authors.initials: M
authors.lastname: Fröhner
authors.forename: Ralph
authors.initials: R
authors.lastname: Hausmann
mesh_terms: D015519:Bone Density / Q000187:drug effects*; D003720:Densitometry; D004164:Diphosphonates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D015337:Multicenter Studies as Topic; D010024:Osteoporosis / Q000517:prevention & control; D010919:Placebos; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D000077211:Zoledronic Acid
chemical_list: D004164:Diphosphonates; D007093:Imidazoles; D010919:Placebos; D000077211:Zoledronic Acid